Lipophilic β-Blockers and Suicide in the Elderly

Jonathan S Zipursky¹, Erin M Macdonald, Jin Luo+5

• ¹Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences and Li Ka Shing Knowledge Institute, St Michael's Hospital and Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences and Li Ka Shing Knowledge Institute, St Michael's Hospital and Institute of Health Policy Management, and Evaluation, University of Toronto and Applied Health Research Centre, St Michael's Hospital, Toronto, Ontario, Canada and King Saud University, Riyadh, Saudi Arabia; Institute for Clinical Evaluative Sciences and Institute of Health Policy, Management and Evaluation, University of Toronto and Department of Family Medicine, McMaster University Hamilton, Ontario, Canada, Canada; Department of Medicine, Sunnybrook Health Sciences Centre and Institute for Clinical Evaluative Sciences and Institute of Health Policy, Management and Evaluation, University of Toronto and Sunnybrook Research Institute, Toronto, Ontario, Canada. dnj@ices.on.ca.